WOCKHARDT
|
|
BOM : 532300     NSE : WOCKPHARMA     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : Average [>25% and <50%] |
Jul 05,2022 |
Price(EOD): ₹ 205.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 2,964.14 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
WOCKHARDT | -1.9% | -21.7% | -58.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.3% | -3% | 21% |
DIVIS LABORATORIES | 0.7% | 3.1% | -16.5% |
DR REDDYS LABORATORIES | 0.6% | 1.9% | -19.6% |
CIPLA | -0.8% | -3.9% | -4.9% |
GLAND PHARMA | -4.6% | -11.1% | -23% |
PIRAMAL ENTERPRISES | 2% | -5.5% | -29.9% |
CADILA HEALTHCARE | 1.5% | -0.9% | -43.6% |
TORRENT PHARMACEUTICALS | 1.8% | 4.2% | -0.7% |
FUNDAMENTAL ANALYSIS OF WOCKHARDT
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF WOCKHARDT
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
3.32
P/E Calculated based on EPS of 61.93
[ Mar2021 - Consolidated Results ] 0.68
P/B Calculated based on Book Value of 302.33
[ Mar2021 - Consolidated Results ] 0.92
P/S Calculated based on Revenues of 3230.44 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA -54% -52% |
SHARE PRICE MOMENTUM OF WOCKHARDT
WOCKHARDT vs SENSEX
DEBT OF WOCKHARDT
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
1.02 1.94 1.58 1.51 |
0.7 1.22 1.28 1.07 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF WOCKHARDT
Pledged Promoter Shares |
43.6 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF WOCKHARDT
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-23.29% -129.61% -1114.99% -17670.6% |
3.64% 58.75% -94.94% -190.65% |
QtrlyTrend |
-4 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
WOCKHARDT related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 250 SMALLCAP | 0.3% | -5.4% | -3.7% |
S&P BSE HEALTHCARE | 0.2% | -1.2% | -14.9% |
S&P BSE SMALL CAP | 0.2% | -5.2% | -0.9% |
S&P BSE 400 MIDSMALLCAP | 0.1% | -4.5% | -2% |
S&P BSE ALLCAP | -0% | -4.4% | 0.1% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP250 | 0.1% | -6.1% | -3.4% |
NIFTY MID SMALL400 | 0.1% | -4.6% | -1.4% |
NIFTY500 MULTICAP 50:25:25 | 0% | -4.7% | -0.7% |
NIFTY 500 | -0% | -4.4% | -0.1% |
You may also like the below Video Courses
FAQ about WOCKHARDT
Is WOCKHARDT good for long term investment?
As on Jul 05,2022, the Fundamentals of WOCKHARDT look Poor and hence it may not be good for long term investment ! See Financial Performance of WOCKHARDT . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is WOCKHARDT UnderValued or OverValued?
As on Jul 05,2022, WOCKHARDT is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of WOCKHARDT ?
As on Jul 05,2022, the Intrinsic Value of WOCKHARDT is Rs. 437.91 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -226.06
Fair Value [Median EV / Sales Model] : Rs. 446.89
Fair Value [Median Price / Sales Model] : Rs. 428.93
Median Fair Value of WOCKHARDT : Rs. 437.91
Is WOCKHARDT trading at a Premium or Discount?
As on Jul 05,2022, WOCKHARDT is trading at a Discount of -53% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
